Post-IPO Equity - X4 Pharmaceuticals - Jun 30, 2022 Funding Round Profile - Cointime

Bitcoin $99,320.15 +2.23%
Ethereum $3,384.29 +8.20%
BNB $629.88 +2.90%
Optimism $2.06 +20.29%
Arbitrum $0.79 +11.93%
Solana $260.42 +7.96%
Polygon $0.46 +4.71%
Cosmos $6.58 +5.87%
Avalanche $36.05 +6.08%

Bitcoin $99,320.15 +2.23%
Ethereum $3,384.29 +8.20%
BNB $629.88 +2.90%
Optimism $2.06 +20.29%
Arbitrum $0.79 +11.93%
Solana $260.42 +7.96%
Polygon $0.46 +4.71%
Cosmos $6.58 +5.87%
Avalanche $36.05 +6.08%

X4 Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 55M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Acorn Bioventures	-	Yes	-	Detail
Lumira Ventures	-	Yes	-	Detail
New Enterprise Associates	-	Yes	-	Detail
Hercules Capital	-	-	-	Detail
AXA Investment Managers	-	-	-	Detail
Bain Capital Life Sciences	-	-	-	Detail
OrbiMed	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 16, 2017	Series A	0	Thynk Capital, LLC.	Detail
Mar 19, 2021	Post-IPO Equity	$ 55M	Abingworth,Altium Capital,etc.	Detail
Nov 16, 2017	Series B	$ 27M	Cormorant Asset Management	Detail
Dec 15, 2015	Series A	$ 37.49M	Cormorant Asset Management	Detail
Jan 1, 2014	Seed	0	SV Health Investors	Detail
Nov 17, 2017	IPO	0		Detail